The Brown University Child and Adolescent Psychopharmacology Update articles from September 2007

The Brown University Child and Adolescent Psychopharmacology Update archives from September 2007

FDA warnings about SSRIs lead to decline in pediatric depression diagnosis.(Special Update on SSRI Use in Children)(selective serotonin reuptake inhibitor)
September 1, 2007... Communications from the Food and Drug Administration (FDA) about suicidality risk for pediatric patients taking selective serotonin reuptake inhibitor (SSRI) antidepressants led not only to a decrease in SSRI prescriptions for young people...

Adding CBT to SSRI treatment of teen depression may not impact efficacy.(ADAPT Study Results)(cognitive behavioral therapy, selective serotonin reuptake inhibitor )
September 1, 2007... There is no evidence that cognitive behavioral therapy (CBT) combined with a selective serotonin reuptake inhibitor (SSRI) is superior to SSRI monotherapy in improving adolescent depression, according to results from the adolescent depression...

Adding sertraline to CBT for PTSD: benefits questionable.(What's New In Research)(post-traumatic stress disorder, cognitive behavioral therapy)
September 1, 2007... According to findings from a small clinical trial, sexually abused children and adolescents with post-traumatic stress disorder (PTSD) should receive trauma-focused cognitive behavioral therapy (TF-CBT) before having an SSRI added to their...

Effects of risperidone on cognitive function in children with disruptive behaviors.(What's New In Research)
September 1, 2007... Risperidone does not appear to alter cognitive function in children with below-average intelligence and disruptive behavior disorders (DBDs) according to data from 2 short-term, double-blind, placebo-controlled studies. In 3 long-term...

Symptoms of mental retardation and autism reversed in laboratory mice.(News Notes)(Picower Institute for Learning and Memory)(Brief article)
September 1, 2007... In a laboratory study with mice, researchers from the Picower Institute for Learning and Memory at the Massachusetts Institute of Technology have reversed the symptoms of Fragile X Syndrome, one of the leading causes of autism and mental...

Hypnosis as therapy in pediatric patients.(News Notes)(Brief article)
September 1, 2007... In a short review of studies that have used hypnosis as a therapeutic tool in children, researchers from Yale University School of Medicine conclude that hypnotic treatment is a particularly suitable intervention for children, in part,...

Methylphenidate may affect developing brain.(News Notes)(Brief article)
September 1, 2007... In a study investigating the effects of methylphenidate in very young rats, researchers at the Weill Cornell Medical College in New York City found alterations in areas of the brain linked to appetite, addiction, higher executive functioning,...

ECT for treating lithium-induced catatonia.(Case Report)(electroconvulsive therapy)(Case study)
September 1, 2007... Patient: Female, 16 y.o. Treatments: Olanzapine (Zyprexa), escitalopram (Lexapro), electroconvulsive therapy (ECT), lithium Case: In May 2005, 16-year-old girl presented for the first time with severe depressive episode with...

[check] FDA to review aripiprazole (Abilify) as adjunctive treatment for depression.(From the FDA)
September 1, 2007... The U.S. Food and Drug Administration (FDA) granted a priority review for the supplemental New Drug Application (sNDA) of aripiprazole (Abilify) for the treatment of adults with major depressive disorder as adjunctive to antidepressant...

Risperidone (generic).(Risperdal (BRAND))(Drug overview)
September 1, 2007... CLASSIFICATION: Atypical antipsychotic. COMMON USAGE: Risperidone has FDA-approved indications for the treatment of schizophrenia in adults and for the short- term treatment of acute mania or mixed episodes associated with bipolar...